Categoría

ENFERMEDADES RARAS

Home > Áreas Terapéuticas > ENFERMEDADES RARAS

Castelbón FJ, Barreda M, Arranz E, Hernández ME, Solares I, Morales M, Muñoz A, Casado A, Yébenes M, Guillén E

 

 

The burden of disease and quality of life in patients with acute hepatic porphyria: COPHASE study
Med Clin (Barc). 2024 Feb 9;162(3):103-111

MÁS INFORMACIÓN

Castelbón Fernández FJ, Barreda Sánchez M, Arranz Canales E, Hernández Contreras ME, Solares Fernández I, Morales Conejo M, Muñoz Cuadrado A, Casado Gómez A, Yébenes Cortés M, Guillén Navarro E

 

Calidad de vida de los pacientes con porfiria hepática aguda con ataques recurrentes en España. Estudio COPHASE
XIV Congreso Nacional de la Sociedad Española de Errores Congénitos del Metabolismo. Santiago de Compostela. 15-17 dic 2021

POSTER

 

de Andrés-Nogales F, Cruz E, Calleja MA, Delgado O, Gorgas Torner MQ, Espín J, Mestre-Ferrándiz J, Palau F, Ancochea A, Arce R, Domínguez-Hernández R, Casado MA and on behalf of the FinMHU-MCDA Group

 

A Multi-Stakeholder Multicriteria Decision Analysis for the Reimbursement of Orphan Drugs (FinMHU-MCDA study)
Orphanet J Rare Dis. 2021 Apr 26;16(1):186

de Andrés-Nogales F, Cruz E, Calleja MÁ, Delgado O, Gorgas -Torner MQ, Espin J, Mestre-Ferrandiz J, Palau F, Ancochea A, Arce R, Domínguez-Hernández R, Casado MA, FinMHU-MCDA Group

 

A Multi-Stakeholder Multicriteria Decision Analysis in Rare Diseases: Reimbursement Criteria for Orphan Drugs in Spain (FinMHU-MCDA study)
23rd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Virtual. 16-19 nov 2020

POSTER

de Andrés-Nogales F, Calleja- Hernández MA, Delgado- Sánchez O, Gorgas- Torner MQ, Domínguez-Hernández R, Casado -Gómez MA, Arce- Delgado R; Grupo de Trabajo FinMHU-MCDA

 

Análisis de decisión multicriterio multidecisor en enfermedades raras: criterios de financiación de medicamentos huérfanos en España (Estudio FinMHU-MCDA)
65 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria (SEFH). Virtual 20-22 oct 2020

Santamaria R, De Juan-Ribera J, Martinez-Sanchez F, Pendon-Ruiz De Mier V, Gil-Garcia C, Lopez-Ruiz MJ, Casado A, Ordovas M, Espinosa M, Del Pino MD

 

Burden of disease in patients with Fabry disease: Economic burden of health care and non-health care resources consumption
56th Congress of European Renal Association-European Dyalisis and Transplant Association (ERA-EDTA). Budapest (Hungary). 13-16 jun 2019

POSTER

Santamaria R, De Juan-Ribera J, Martinez-Sanchez F, Pendon-Ruiz De Mier V, Gil-Garcia C, Lopez-Ruiz MJ, Casado A, Ordovas M, Espinosa M, Del Pino MD

 

Burden of disease in patients with fabry disease: Health related quality of life and associated factors
56th Congress of European Renal Association-European Dyalisis and Transplant Association (ERA-EDTA). Budapest (Hungary). 13-16 jun 2019

POSTER

Orofino J, Soto J, Casado MA, Oyagüez I

 

 

 

Global spending on orphan drugs in the main European markets (France, Germany, United Kingdom, Italy and Spain) during 2007
Appl Health Econ Health Policy. 2010;8(5):301-15